Back to Search Start Over

Ex Situ Arterial Reconstruction During Normothermic Perfusion of the Liver.

Authors :
Nasralla D
Lembach H
Mergental H
Mirza D
Friend P
Muiesan P
Perera M
Source :
Transplantation direct [Transplant Direct] 2020 Aug 21; Vol. 6 (9), pp. e596. Date of Electronic Publication: 2020 Aug 21 (Print Publication: 2020).
Publication Year :
2020

Abstract

Background: Aberrant hepatic arterial anatomy may be seen in up to 30% of liver grafts, and reconstruction prolongs the cold ischemic time or the arterialization times. If normothermic machine preservation (NMP) is used to preserve liver grafts, the presence of aberrant arterial anatomy poses a challenge. Dual arterial cannulation is a temporary solution to enable effective perfusion, until optimal circumstances are met for arterial reconstruction, without compromising ischemia time. To date the technical and logistical feasibility of arterial reconstruction ex situ and during NMP has not been reported.<br />Methods: Series of 5 cases from the Consortium for Organ Preservation in Europe randomized controlled trial in which grafts with arterial anatomic variations were reconstructed while organs were perfused on NMP.<br />Results: One donor after cardiac death and 4 donor after brain death livers with arterial anatomical variations reconstructed while on NMP were included. All patients survived transplantation, spending 1-7 d in intensive care unit and discharged home after 5-15 d. None of the cases developed early allograft dysfunction or any early technical complications. At follow-up, there were no late hepatic artery thrombosis, stenosis, or any other vascular-related complication. Four of 5 patients underwent magnetic resonance cholangiopancreatography at 6 mo with no evidence of ischemic cholangiopathy.<br />Conclusions: The case series described above suggests that ex vivo arterial reconstruction surgery on liver grafts while on board the NMP device is feasible, safe, and effective.<br />Competing Interests: P.F. is cofounder, Chief Medical Officer, and consultant to OrganOX Limited and also holds shares in the company. D.M. holds minor shares in OrganOX Limited. The other authors declare no conflicts of interest.<br /> (Copyright © 2020 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.)

Details

Language :
English
ISSN :
2373-8731
Volume :
6
Issue :
9
Database :
MEDLINE
Journal :
Transplantation direct
Publication Type :
Academic Journal
Accession number :
32904023
Full Text :
https://doi.org/10.1097/TXD.0000000000001040